Literature DB >> 1629180

The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells.

P A Marcotte1, I M Kozan, S A Dorwin, J M Ryan.   

Abstract

The enzyme responsible for the metalloproteinase activity which cleaves the Glu143-Leu144 bond of (pro)urokinase has been isolated from the conditioned medium of cultured normal human kidney cells. Using S-Sepharose and Cibacron Blue-agarose chromatography, then C-4 reversed phase high pressure liquid chromatography, a protein of about 20,000 Da was isolated. Through an identical amino-terminal sequence, the protein was shown to be the matrix metalloproteinase previously referred to in the literature as "pump-1" (putative metalloproteinase). When aprotinin was added during the course of the purification, the major species isolated was the zymogen form (28,000 Da) of pump-1. Pump-1 has been shown to efficiently cleave the susceptible bond of both pro-urokinase (single-chain) and active (two-chain) urokinase and thereby produce the corresponding low molecular weight forms. The amino-terminal sequences of the A and B chains of low molecular weight urokinase prepared by action of pump-1 on recombinant high molecular weight urokinase are identical to those of the low molecular weight urokinase isolated from human kidney cell culture. Since the reaction of urokinase with this metalloproteinase results in separation of its serine proteinase region from the domain which mediates binding to the urokinase receptor, it may be of importance in the regulation of the functional activity of the plasminogen activator in cellular processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629180

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.

Authors:  U K Saarialho-Kere; S O Kovacs; A P Pentland; J E Olerud; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.

Authors:  D A Fishman; A Kearns; S Larsh; J J Enghild; M S Stack
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  Matrilysin: expression, purification, and characterization.

Authors:  D Soler; T Nomizu; W E Brown; Y Shibata; D S Auld
Journal:  J Protein Chem       Date:  1995-10

Review 4.  Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

5.  In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.

Authors:  L Damstrup; B Rude Voldborg; M Spang-Thomsen; N Brünner; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

6.  Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

Authors:  L R Lund; J Rømer; N Thomasset; H Solberg; C Pyke; M J Bissell; K Danø; Z Werb
Journal:  Development       Date:  1996-01       Impact factor: 6.868

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.